Hill-Rom Holdings (HRC) Tops Q1 EPS by 5c, Slight Beat on Revenues; Offers Q2 & FY20 EPS Guidance
Get Alerts HRC Hot Sheet
Join SI Premium – FREE
Hill-Rom Holdings (NYSE: HRC) reported Q1 EPS of $1.13, $0.05 better than the analyst estimate of $1.08. Revenue for the quarter came in at $685 million versus the consensus estimate of $684.01 million.
"We are pleased to report another quarter of strong financial results driven by our diverse portfolio and successful execution of our strategic priorities," said John Groetelaars, Hillrom president and CEO. "Our category leadership strategy, new products, emerging market opportunities and benefits from recent acquisitions position us well to drive sustainable growth, deliver on our financial outlook and enhance outcomes for patients and their caregivers."
GUIDANCE:
Hill-Rom Holdings sees Q2 2020 EPS of $1.14-$1.16, versus the consensus of $1.24.
Hill-Rom Holdings sees FY2020 EPS of $5.50-$5.56, versus the consensus of $5.52.
For the full-year 2020, Hillrom continues to expect revenue to increase 1 to 2 percent on both a reported and constant currency basis, and core revenue to increase 5 to 6 percent. Excluding the incremental benefit of acquisitions prior to the anniversary date, core revenue is expected to increase 4 to 5 percent. The company now expects adjusted earnings, excluding special items, of $5.50 to $5.56 per diluted share, and approximately $430 million in operating cash flow.
For the fiscal second quarter 2020, Hillrom expects revenue to decline 1 to 2 percent on a reported and constant currency basis, and core revenue to increase approximately 4 percent including the contribution from acquisitions of approximately 200 basis points. The company expects adjusted earnings, excluding special items, of $1.14 to $1.16 per diluted share.
For earnings history and earnings-related data on Hill-Rom Holdings (HRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share